German industrial giant Siemens AG said today it will pay $5.1 billion to acquire the life sciences data startup Dotmatics in ...
Siemens Agrees to Buy Dotmatics for $5.1 Billion, Expanding AI Portfolio to Life Sciences — Update
Siemens has agreed to acquire Dotmatics for $5.1 billion, a combination the companies said would use artificial intelligence to speed up development cycles and help make breakthroughs in the ...
The deal extends Siemens’s artificial-intelligence-powered product-lifecycle-management portfolio and increases the company’s ...
Siemens AG announces that it has signed an agreement to acquire Dotmatics, a leading provider of Life Sciences R&D software ...
Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight Partners ...
Siemens has agreed to acquire Dotmatics, a life-science research-and-development software company, for $5.1 billion, the companies said Wednesday. The deal will be financed primarily through the sale ...
Explore more
Siemens AG and Siemens Healthineers AG have each provided €100,000 in immediate assistance to mitigate the suffering of earthquake victims in Myanmar and Thailand.
Siemens partners with Miko Pharma to develop cutting-edge pharmaceutical manufacturing facilities in Ghana. The agreement ...
GE HealthCare, Siemens Healthineers and Philips are working on generative AI products that aggregate patient data to make ...
The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the ...
The firm's Innovance Antithrombin assay is used to monitor antithrombin activity levels in hemophilia patients and aid dosing decisions for a routine prophylaxis.
The antithrombin assay will support dosing Qfitlia, the sixth Alnylam-discovered RNAi medicine to receive FDA approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results